Jeffrey Dunn
Impact in
-
- Multiple Sclerosis Research Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
-
- Multiple Sclerosis Research Studies 11
- Oncology 8
- CAR-T cell therapy research 3
- Polyomavirus and related diseases 3
- Global Cancer Incidence and Screening 2
- Co-authors
- Andrew R. BlightStan DeresinskiDavid J. EpsteinOliver EltheringtonG. BellAmy E. AndersonTony FouweatherElaine McColl
- Journals
- Phytochemistry (4 papers)Neurology (3 papers)Multiple Sclerosis Journal (2 papers)Multiple Sclerosis and Related Disorders (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesSlovakiaAustralia
In The Last Decade
Jeffrey Dunn
29 papers receiving 934 citations
Peers
Comparison fields: 5 of 116
- Pathology and Forensic Medicine 376
- Immunology 345
- Neurology 162
- Rheumatology 114
- Parasitology 44
Countries citing papers authored by Jeffrey Dunn
This map shows the geographic impact of Jeffrey Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Dunn more than expected).
Fields of papers citing papers by Jeffrey Dunn
This network shows the impact of papers produced by Jeffrey Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Dunn. The network helps show where Jeffrey Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 39 | |
| 9 | 2018 | 2 | |
| 10 | 2016 | 244 | |
| 11 | 2013 | 11 | |
| 12 | 2011 | 80 | |
| 13 | 2010 | 62 | |
| 14 | 2009 | 4 | |
| 15 | 2008 | 33 | |
| 16 | 1992 | 43 | |
| 17 | 1984 | 9 | |
| 18 | 1982 | 27 | |
| 19 | 1982 | 26 | |
| 20 | Cancer of the lung and Los-Angeles-type air pollution | 1967 | 19 |
About Jeffrey Dunn
Jeffrey Dunn is a scholar working on Pathology and Forensic Medicine, Oncology, Rheumatology, Neurology and Immunology, having authored 34 papers that have together received 986 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (3 papers), CAR-T cell therapy research (3 papers), Polyomavirus and related diseases (3 papers), Herpesvirus Infections and Treatments (3 papers), Global Cancer Incidence and Screening (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (376 citations), Immunology (345 citations), Neurology (162 citations), Rheumatology (114 citations) and Parasitology (44 citations). Jeffrey Dunn has collaborated with scholars based in United States, Slovakia and Australia. Frequent co-authors include Andrew R. Blight, Stan Deresinski, David J. Epstein, Oliver Eltherington, G. Bell, Amy E. Anderson, Tony Fouweather, Elaine McColl, Catharien M. U. Hilkens and John D. Isaacs. Their work appears in journals such as Phytochemistry, Neurology, Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.